ACE2, part of the renin-angiotensin system (RAS), paradoxically plays both protective and tumor-promoting roles: while it mitigates angiotensin II-mediated damage in cardiovascular systems, its elevated expression in CRC is associated with increased tumor aggressiveness and poor prognosis (5). This evidence concerns the gene ACE2 and neoplasm.